Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul;62(1):258-270.
doi: 10.1002/jmri.29695. Epub 2025 Jan 9.

Presence of Fragmented Intratumoral Thrombosed Microvasculature in the Necrotic and Peri-Necrotic Regions on SWI Differentiates IDH Wild-Type Glioblastoma From IDH Mutant Grade 4 Astrocytoma

Virendra Kumar Yadav  1 , Shalini Sharma  2 , Satyajit Maurya  1 , Rakesh K Singh  2 , Jitendra Saini  3 , Preeti Jain  4 , Rana Patir  5 , Sunita Ahlawat  4 , Sumanta Das  3 , Sandeep Vaishya  5 , Sumeet Agarwal  6   7 , Anup Singh  1   7 , Rakesh K Gupta  2
Affiliations

Presence of Fragmented Intratumoral Thrombosed Microvasculature in the Necrotic and Peri-Necrotic Regions on SWI Differentiates IDH Wild-Type Glioblastoma From IDH Mutant Grade 4 Astrocytoma

Virendra Kumar Yadav et al. J Magn Reson Imaging. 2025 Jul.

Abstract

Background: Isocitrate dehydrogenase (IDH) wild-type (IDHwt) glioblastomas (GB) are more aggressive and have a poorer prognosis than IDH mutant (IDHmt) tumors, emphasizing the need for accurate preoperative differentiation. However, a distinct imaging biomarker for differentiation mostly lacking. Intratumoral thrombosis has been reported as a histopathological biomarker for GB.

Purpose: To evaluate the fragmented intratumoral thrombosed microvasculature (FTV) signs on susceptibility-weighted imaging (SWI) for distinguishing IDHwt and IDHmt tumors.

Study type: Retrospective.

Subjects: Ninety-seven treatment-naïve patients with histopathologically confirmed IDHwt GB (54 males, 26 females) and IDHmt grade 4 astrocytoma (13 males, 4 females).

Field strength/sequence: 3-T, SWI, fluid-attenuated-inversion-recovery (FLAIR), T1-weighted, T2-weighted, PD-weighted, post-contrast T1-weighted and dynamic-contrast-enhanced (DCE)-MRI.

Assessment: SWI data were evaluated by three experienced neuroradiologists (S.S., 11 years; J.S., 15 years; R.K.G., 40 years of experience), who assessed FTV presence in necrotic and peri-necrotic regions. FTV was identified as intratumoral susceptibility signal having minimal or no interslice connections. Quantitative DCE-MRI parameters were derived using first-pass-analysis and extended Tofts model. FLAIR abnormal, contrast-enhancing, and necrotic regions were segmented using in-house developed U-Net architecture.

Statistical tests: Fleiss' Kappa, Cohen's Kappa, Shapiro-Wilk test, t tests or Mann-Whitney U test, receiver-operating characteristic (ROC) analysis, confusion matrix. A P-value <0.05 was considered statistically significant.

Results: Fleiss' kappa test provided 91% inter-rater agreement, and Cohen's kappa provided intrarater agreement ranged from 81% to 97%. The raters' accuracy in distinguishing IDHwt from IDHmt ranged from 92% to 94%. Some of the quantitative DCE-MRI parameters (CBV, Ve, and Ktrans) provided statistically significant differences in differentiating IDHwt and IDHmt. Ktrans demonstrated 80.3% sensitivity and 81.2% specificity, with ROC analysis showing an AUC of 0.77.

Data conclusion: FTV signs in necrotic and peri-necrotic regions on SWI demonstrated a high accuracy in distinguishing IDHwt from IDHmt. Qualitative assessment of FTV signs showed almost perfect inter-rater and intrarater agreement. Quantitative DCE-MRI metrics also showed statistically significant differentiation of IDHwt and IDHmt.

Plain language summary: This study demonstrates that preoperative imaging, particularly the visualization of the fragmented thrombosed vasculature (FTV) sign on susceptibility-weighted imaging (SWI), effectively differentiates isocitrate dehydrogenase (IDH) wild-type (IDHwt) glioblastoma (GB) from IDH mutant (IDHmt) grade 4 astrocytomas. Over 90% of IDHwt GB patients displayed the FTV sign, a specific imaging biomarker absent in IDHmt cases. Perfusion parameters such as cerebral blood volume, Ve, and Ktrans were elevated in IDHwt gliomas, reflecting distinct vascular profiles. SWI offers a noninvasive and accurate diagnostic method, overcoming limitations of histopathology. Despite limitations like unequal sample sizes and retrospective analysis, this study underscores the clinical potential of SWI in improving glioma characterization and aiding treatment planning.

Level of evidence: 4 TECHNICAL EFFICACY: Stage 2.

Keywords: dynamic contrast‐enhanced MRI; glioblastomas; imaging biomarker; susceptibility‐weighted imaging; tumor classification.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Sengupta A, Agarwal S, Gupta PK, et al. On differentiation between vasogenic edema and non‐enhancing tumor in high‐grade glioma patients using a support vector machine classifier based upon pre and post‐surgery MRI images. Eur J Radiol 2018;106(299):199‐208. https://doi.org/10.1016/j.ejrad.2018.07.018.
    1. Sengupta A, Ramaniharan AK, Gupta RK, Agarwal S, Singh A. Glioma grading using a machine‐learning framework based on optimized features obtained from T1 perfusion MRI and volumes of tumor components. J Magn Reson Imaging 2019;50(4):1295‐1306. https://doi.org/10.1002/JMRI.26704.
    1. Gupta M, Gupta A, Yadav V, et al. Comparative evaluation of intracranial oligodendroglioma and astrocytoma of similar grades using conventional and T1‐weighted DCE‐MRI. Neuroradiology 2021;63(8):1227‐1239. https://doi.org/10.1007/S00234-021-02636-8/METRICS.
    1. Parvaze PS, Bhattacharjee R, Verma YK, et al. Quantification of radiomics features of peritumoral vasogenic edema extracted from fluid‐attenuated inversion recovery images in glioblastoma and isolated brain metastasis, using T1‐dynamic contrast‐enhanced perfusion analysis. NMR Biomed 2023;36(5):e4884. https://doi.org/10.1002/NBM.4884.
    1. OncoLink. Adult glioma: Grading and treatment. Accessed on April 25, 2024. Available from: https://www.oncolink.org/cancers/brain-tumors/adult-glioma-grading-and-t....

MeSH terms

Substances